EMPATICC-2 (AF+VT) - Cardiac Arrhythmias in Advanced Cancer
People with advanced cancer have an increased risk of developing cardiac arrhythmias. These often remain undetected but could lead to serious complications, including stroke, hospitalization, or sudden cardiac death. However, little is known about how frequently these arrhythmias occur and how they affect survival and the course of the disease.
In the EMPATICC-2 research project, Dr. Markus Anker and his team investigate cardiac arrhythmias in patients with advanced cancer using small monitors implanted beneath the skin to continuously record heart rhythms. The devices are implanted only when clinically indicated, independently of study participation. The focus is on atrial fibrillation and potentially dangerous ventricular arrhythmias.
The aim is to detect cardiac arrhythmias earlier, better understand their prognostic significance, and ultimately improve cardiovascular care for people living with cancer.
Website working group cardio-oncology (AG Anker):
https://www.dhzc.charite.de/forschung/eintrag/ag-anker-189/